NeoGenomics offers unparalleled services to accelerate your complex drug development program and clinical trials, supported by a network
of College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories.
Where trust meets results - 300+ biopharma partners
At NeoGenomics, we understand the needs of pharmaceutical and biotechnology companies, and we align with our partners to support development of therapies that will save lives. With over a decade of experience, we are a trusted partner in oncology research and development, delivering solutions to advance your drug development and clinical trial programs for targeted therapies and emerging treatment modalities.
No matter the scale or business need, we deliver:
- Seamless end-to-end multimodal testing services, eliminating the need for multiple vendors
- Broad biopharmaceutical test menu and integrated data analysis
- Advanced customized solutions to accelerate your development program
- Deep scientific and technical expertise with MDs, PhDs, and dedicated project managers ensuring project integrity
- In-house regulatory and compliance team to effectively navigate complex regulatory processes and support submissions
- Certified pathology staff capable of performing US FDA-approved companion diagnostic confirmations
- Large-scale, real-world oncology data to better inform clinical trials
Lab services
Cell therapy solutions
Antibody-drug conjugates (ADCs) solutions
Biomarker solutions
Real-time molecular insights
RaDaR ST provides tumor-informed MRD detection, identifying residual ctDNA with confidence. MRD tests can help biopharma companies optimize clinical trial design by enriching trial populations, following response to treatment, and as a surrogate endpoint for clinical trials.
Unlock the complexities of every tumor
Clinically and analytically validated Comprehensive Genomic Profiling (CGP) assays across both tissue and liquid biopsy, providing biopharma partners with actionable genomic insights to confidently advance precision oncology development.
Paletrra is a comprehensive, end-to-end, AI-driven spatial proteomics solution that transforms your precious tissue into deep visual insights - empowering confident decisions and accelerating therapeutic advancement. Paletrra’s whole-tissue workflow, AI-driven image analysis, and advanced spatial analytics unlocks salient biological insights. With both off-the-shelf test menu and customization option, Paletrra is delivered through high-touch collaboration backed by scientific expertise.
NeoGenomics delivers thoughtful oversight to ensure compliance with federal regulations for a successful commercial launch. We provide in-house regulatory and compliance support to our pharma and biotech partners to support their clinical trial requirements, and we have enjoyed a 100% success rate with institutional review board (IRB) and FDA submissions,* often receiving consistent favorable FDA feedback.
More info on regulatory support
*Data on file.
The use of biological signatures to identify patients who are likely to benefit from a particular therapy has greatly accelerated the pace of drug development and approval. Simultaneously, it has complicated drug development by requiring the co-development of a companion diagnostic (CDx) assay to accurately and reproducibly select patients who are likely to benefit from said therapy. We provide specialized scientific expertise to ensure CDx success and accelerate your pipeline progress.
We are pleased to offer complete end-to-end support throughout the commercialization process. NeoGenomics is one of the largest oncology-focused laboratories in the United States, with established relationships with major in vitro diagnostic (IVD) providers, single-site FDA-approved test approvals, and partnerships for ex-US launch needs.
Our commitment to advancing cancer care with real-world multi-modal oncology data solutions makes us a valuable partner to pharmaceutical companies.
Understanding the vital role that data play in precision oncology, NeoGenomics has the scientific expertise and innovation to help pharma companies succeed sooner.
Partner testimonials
Check out our latest precision medicine resources
Use the form below to access our full library of white papers, on demand webinars and case studies. We invite you to check on this library often for newly added content.
Review our variety of publications and poster presentations.
